{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T20:10:06Z","timestamp":1745007006718,"version":"3.40.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,18]]},"DOI":"10.7759\/cureus.82533","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T19:48:20Z","timestamp":1745005700000},"source":"Crossref","is-referenced-by-count":0,"title":["Refractory Immune Thrombocytopenic Purpura With Low Immature Platelet Fraction"],"prefix":"10.7759","author":[{"given":"Kabeer","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany","family":"Scotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy M","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramod","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.88a.20201","article-title":"Updated guidelines for immune thrombocytopenic purpura: Expanded management options","volume":"88","author":"DeSouza S","year":"2021","unstructured":"DeSouza S, Angelini D. Updated guidelines for immune thrombocytopenic purpura: Expanded management options. Cleve Clin J Med. 2021, 88:664-8. 10.3949\/ccjm.88a.20201","journal-title":"Cleve Clin J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2022.11.022","article-title":"Current approaches for the diagnosis and management of immune thrombocytopenia","volume":"108","author":"Gafter-Gvili A","year":"2023","unstructured":"Gafter-Gvili A. Current approaches for the diagnosis and management of immune thrombocytopenia. Eur J Intern Med. 2023, 108:18-24. 10.1016\/j.ejim.2022.11.022","journal-title":"Eur J Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2021.03.023","article-title":"Diagnostic characteristics of immature platelet fraction for the assessment of immune thrombocytopenia","volume":"202","author":"Pereira KN","year":"2021","unstructured":"Pereira KN, de Carvalho JA, Paniz C, Moresco RN, da Silva JE. Diagnostic characteristics of immature platelet fraction for the assessment of immune thrombocytopenia. Thromb Res. 2021, 202:125-7. 10.1016\/j.thromres.2021.03.023","journal-title":"Thromb Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-2243","article-title":"The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review","volume":"139","author":"Hui P","year":"2011","unstructured":"Hui P, Cook DJ, Lim W, Fraser GA, Arnold DM. The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. Chest. 2011, 139:271-8. 10.1378\/chest.10-2243","journal-title":"Chest"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2011.013","article-title":"Prevalence and course of pseudothrombocytopenia in outpatients","volume":"49","author":"Froom P","year":"2011","unstructured":"Froom P, Barak M. Prevalence and course of pseudothrombocytopenia in outpatients. Clin Chem Lab Med. 2011, 49:111-4. 10.1515\/CCLM.2011.013","journal-title":"Clin Chem Lab Med"},{"key":"ref6","article-title":"Thrombocytopenia: evaluation and management","volume":"106","author":"Gauer RL","year":"2022","unstructured":"Gauer RL, Whitaker DJ. Thrombocytopenia: evaluation and management. Am Fam Physician. 2022, 106:288-98.","journal-title":"Am Fam Physician"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2017.12.015","article-title":"Hematological profile associated with type 2 diabetes mellitus","volume":"12","author":"Kachekouche Y","year":"2018","unstructured":"Kachekouche Y, Dali-Sahi M, Benmansour D, Dennouni-Medjati N. Hematological profile associated with type 2 diabetes mellitus. Diabetes Metab Syndr. 2018, 12:309-12. 10.1016\/j.dsx.2017.12.015","journal-title":"Diabetes Metab Syndr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25071667","article-title":"A pilot study on the effect of anti-thrombopoietin antibody on platelet count in patients with type 2 diabetes","volume":"25","author":"Fukuda T","year":"2020","unstructured":"Fukuda T, Hamaguchi M, Osaka T, et al.. A pilot study on the effect of anti-thrombopoietin antibody on platelet count in patients with type 2 diabetes. Molecules. 2020, 25:1667. 10.3390\/molecules25071667","journal-title":"Molecules"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-004-2272-y","article-title":"Thrombotic microangiopathy: an atypical cause of acute renal failure in patients with acute pancreatitis","volume":"30","author":"Boyer A","year":"2004","unstructured":"Boyer A, Chadda K, Salah A, Bonmarchand G. Thrombotic microangiopathy: an atypical cause of acute renal failure in patients with acute pancreatitis. Intensive Care Med. 2004, 30:1235-9. 10.1007\/s00134-004-2272-y","journal-title":"Intensive Care Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/acer.13295","article-title":"Ethanol induces platelet apoptosis","volume":"41","author":"Liu L","year":"2017","unstructured":"Liu L, Chen M, Zhao L, et al.. Ethanol induces platelet apoptosis. Alcohol Clin Exp Res. 2017, 41:291-8. 10.1111\/acer.13295","journal-title":"Alcohol Clin Exp Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1810479","article-title":"Immune thrombocytopenia","volume":"381","author":"Cooper N","year":"2019","unstructured":"Cooper N, Ghanima W. Immune thrombocytopenia. N Engl J Med. 2019, 381:945-55. 10.1056\/NEJMcp1810479","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-023-03672-1","article-title":"Reference guide for the diagnosis of adult primary immune thrombocytopenia, 2023 edition","volume":"119","author":"Kashiwagi H","year":"2024","unstructured":"Kashiwagi H, Kuwana M, Murata M, et al.. Reference guide for the diagnosis of adult primary immune thrombocytopenia, 2023 edition. Int J Hematol. 2024, 119:1-13. 10.1007\/s12185-023-03672-1","journal-title":"Int J Hematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert C","year":"2019","unstructured":"Neunert C, Terrell DR, Arnold DM, et al.. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019, 3:3829-66. 10.1182\/bloodadvances.2019000966","journal-title":"Blood Adv"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07995.x","article-title":"Complement activation on platelets correlates with a decrease in circulating immature platelets in patients with immune thrombocytopenic purpura","volume":"148","author":"Peerschke EI","year":"2010","unstructured":"Peerschke EI, Andemariam B, Yin W, Bussel JB. Complement activation on platelets correlates with a decrease in circulating immature platelets in patients with immune thrombocytopenic purpura. Br J Haematol. 2010, 148:638-45. 10.1111\/j.1365-2141.2009.07995.x","journal-title":"Br J Haematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-321398","article-title":"Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia","volume":"117","author":"Barsam SJ","year":"2011","unstructured":"Barsam SJ, Psaila B, Forestier M, et al.. Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia. Blood. 2011, 117:5723-32. 10.1182\/blood-2010-11-321398","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/358247-refractory-immune-thrombocytopenic-purpura-with-low-immature-platelet-fraction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T19:48:21Z","timestamp":1745005701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/358247-refractory-immune-thrombocytopenic-purpura-with-low-immature-platelet-fraction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.82533","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,18]]}}}